Correlation Between Amylyx Pharmaceuticals and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Achilles Therapeutics.
Diversification Opportunities for Amylyx Pharmaceuticals and Achilles Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Amylyx and Achilles is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Achilles Therapeutics
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the Achilles Therapeutics. But the etf apears to be less risky and, when comparing its historical volatility, Amylyx Pharmaceuticals is 1.23 times less risky than Achilles Therapeutics. The etf trades about -0.08 of its potential returns per unit of risk. The Achilles Therapeutics PLC is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 116.00 in Achilles Therapeutics PLC on November 7, 2024 and sell it today you would earn a total of 20.00 from holding Achilles Therapeutics PLC or generate 17.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| Achilles Therapeutics PLC |
Amylyx Pharmaceuticals and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and Achilles Therapeutics
The main advantage of trading using opposite Amylyx Pharmaceuticals and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |